Pediatric Arginine Vasopressin Disorders (Diabetes Insipidus) Clinical Presentation

1. Arima H, Cheetham T, Christ-Crain M, et al, for the Working Group for Renaming Diabetes Insipidus. Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocr J. 2022 Nov 28. 69(11):1281-4. [QxMD MEDLINE Link]. [Full Text].

2. Serbis A, Rallis D, Giapros V, Galli-Tsinopoulou A, Siomou E. Wolfram syndrome 1: a pediatrician's and pediatric endocrinologist's perspective. Int J Mol Sci. 2023 Feb 12. 24(4):3690. [QxMD MEDLINE Link]. [Full Text].

3. Central diabetes insipidus. Orphannet. Available at http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=17999&Disease_Disease_Search_diseaseGroup=diabetes-insipidus&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Central-diabetes-insipidus&title=Central-diabetes-in. July 2012; Accessed: September 15, 2017.

4. Di Iorgi N, Allegri AE, Napoli F, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab. 2014 Apr. 99(4):1264-72. [QxMD MEDLINE Link]. [Full Text].

5. Rutishauser J, Spiess M, Kopp P. Genetic forms of neurohypophyseal diabetes insipidus. Best Pract Res Clin Endocrinol Metab. 2016 Mar. 30(2):249-62. [QxMD MEDLINE Link].

6. Knepper MK, Kwon T, Nielsen S. Molecular physiology of water balance. New Engl J Med. 2015 April 2. 372;14:1349-58. [QxMD MEDLINE Link].

7. Wildin RS, Antush MJ, Bennett RL. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet. 1994 Aug. 55(2):266-77. [QxMD MEDLINE Link].

8. Faerch M, Christensen JH, Corydon TJ, et al. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol (Oxf). 2008 Mar. 68(3):395-403. [QxMD MEDLINE Link].

9. Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab. 2016 Mar. 30(2):263-76. [QxMD MEDLINE Link].

10. Driano JE, Lteif AN, Creo AL. Vasopressin-dependent disorders: What is new in children?. Pediatrics. 2021 May. 147(5):e2020022848. [QxMD MEDLINE Link]. [Full Text].

11. Mulders SM, Bichet DG, Rijss JP, et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest. 1998 Jul 1. 102(1):57-66. [QxMD MEDLINE Link]. [Full Text].

12. Milano S, Carmosino M, Gerbino A, Svelto M, Procino G. Hereditary nephrogenic diabetes insipidus: pathophysiology and possible treatment. An update. Int J Mol Sci. 2017 Nov 10. 18(11):2385. [QxMD MEDLINE Link]. [Full Text].

13. Chandrasekaran K, Karolina DS, Sepramaniam S, et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int. 2012 Apr. 81(7):617-27. [QxMD MEDLINE Link]. [Full Text].

14. Agre P, King LS, Yasui M, et al. Aquaporin water channels - from atomic structure to clinical medicine. J Physiol. 2002. 542:3-16. [QxMD MEDLINE Link].

15. Danziger J, Zeidel ML. Osmotic homeostasis. Clin J Am Soc Nephrol. 2015. 10:852-862. [QxMD MEDLINE Link].

16. Davies JH, Penney M, Abbes AP, et al. Clinical features, diagnosis and molecular studies of familial central diabetes insipidus. Horm Res. 2005. 64(5):231-7. [QxMD MEDLINE Link].

17. Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis. 2005 Apr. 45(4):626-37. [QxMD MEDLINE Link].

18. Hunter JD, Calikoglu AS. Etiological and clinical characteristics of central diabetes insipidus in children: a single center experience. Int J Pediatr Endocrinol. 2016. 2016:3. [QxMD MEDLINE Link]. [Full Text].

19. Werny D, Elfers C, Perez FA, Pihoker C, Roth CL. Pediatric central diabetes insipidus: brain malformations are common and few patients have idiopathic disease. J Clin Endocrinol Metab. 2015 Aug. 100(8):3074-80. [QxMD MEDLINE Link]. [Full Text].

20. Capatina C, Poiana C, Fleseriu M. Pituitary and SARS CoV-2: an unremitting conundrum. Best Pract Res Clin Endocrinol Metab. 2023 Jul. 37(4):101752. [QxMD MEDLINE Link]. [Full Text].

21. Christ-Crain M, Bichet DG, Fenske WK, et al. Diabetes insipidus. Nat Rev Dis Primers. 2019 Aug 8. 5(1):54. [QxMD MEDLINE Link].

22. Juul KV, Schroeder M, Rittig S, Norgaard JP. National surveillance of central diabetes insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients. J Clin Endocrinol Metab. 2014 Jun. 99(6):2181-7. [QxMD MEDLINE Link].

23. Hannon MJ, Crowley RK, Behan LA, et al. Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. J Clin Endocrinol Metab. 2013 Aug. 98(8):3229-37. [QxMD MEDLINE Link]. [Full Text].

24. Timper K, Fenske W, Kuhn F, et al. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J Clin Endocrinol Metab. 2015 Jun. 100(6):2268-74. [QxMD MEDLINE Link]. [Full Text].

25. Urano F. Wolfram syndrome: diagnosis, management, and treatment. Curr Diab Rep. 2016 Jan. 16(1):6. [QxMD MEDLINE Link]. [Full Text].

26. Winzeler B, Zweifel C, Nigro N, et al. Postoperative copeptin concentration predicts diabetes insipidus after pituitary surgery. J Clin Endocrinol Metab. 2015 Jun. 100(6):2275-82. [QxMD MEDLINE Link]. [Full Text].

27. [Guideline] Expert Panel on Neurologic Imaging: Burns J, Policeni B, Bykowski J, et al. ACR Appropriateness Criteria(®) Neuroendocrine Imaging. J Am Coll Radiol. 2019 May. 16(5S):S161-S173. [QxMD MEDLINE Link]. [Full Text].

28. Boussemart T, Nsota J, Martin-Coignard D, Champion G. Nephrogenic diabetes insipidus: treat with caution. Pediatr Nephrol. 2009 Sep. 24(9):1761-3. [QxMD MEDLINE Link].

29. D'Alessandri-Silva C, Carpenter M, Mahan JD. Treatment regimens by pediatric nephrologists in children with congenital nephrogenic diabetes insipidus: A MWPNC study. Clin Nephrol. 2018 May. 89(5):358-63. [QxMD MEDLINE Link].

30. Al Nofal A, Lteif A. Thiazide diuretics in the management of young children with central diabetes insipidus. J Pediatr. 2015 Sep. 167(3):658-61. [QxMD MEDLINE Link].

31. Alon U, Chan JC. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol. 1985. 5(1):9-13. [QxMD MEDLINE Link].

32. Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev. 2000 Apr. 21(4):122-9; quiz 129. [QxMD MEDLINE Link].

33. Smego AR, Backeljauw P, Gutmark-Little I. Buccally administered intranasal desmopressin acetate for the treatment of neurogenic diabetes insipidus in infancy. J Clin Endocrinol Metab. 2016 May. 101(5):2084-8. [QxMD MEDLINE Link]. [Full Text].

34. Mavinkurve M, McGrath N, Johnston N, Moloney S, Murphy NP, Hawkes CP. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus. J Pediatr Endocrinol Metab. 2017 May 24. 30(6):623-8. [QxMD MEDLINE Link].

Karl S Roth, MD Retired Professor and Chair, Department of Pediatrics, Creighton University School of Medicine

Karl S Roth, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Nutrition, American Pediatric Society, American Society for Nutrition, American Society of Nephrology, Association of American Medical Colleges, Medical Society of Virginia, New York Academy of Sciences, Sigma Xi, The Scientific Research Honor Society, Society for Pediatric Research, Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

James CM Chan, MD Professor of Pediatrics, Tufts University School of Medicine; Director of Research, The Barbara Bush Children's Hospital, Maine Medical Center

James CM Chan, MD is a member of the following medical societies: American Pediatric Society, Alpha Omega Alpha, American Academy of Pediatrics, American Physiological Society, American Society of Nephrology, American Society of Pediatric Nephrology, International Society of Nephrology

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London) Professor and Chair, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Greece; UNESCO Chair on Adolescent Health Care, University of Athens, Greece

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London) is a member of the following medical societies: American Academy of Pediatrics, American College of Physicians, American Pediatric Society, American Society for Clinical Investigation, Association of American Physicians, Endocrine Society, Pediatric Endocrine Society, Society for Pediatric Research, American College of Endocrinology

Disclosure: Nothing to disclose.

Robert P Hoffman, MD Professor and Program Director, Department of Pediatrics, Ohio State University College of Medicine; Pediatric Endocrinologist, Division of Pediatric, Endocrinology, Diabetes, and Metabolism, Nationwide Children's Hospital

Robert P Hoffman, MD is a member of the following medical societies: American College of Pediatricians, American Diabetes Association, American Pediatric Society, Christian Medical and Dental Associations, Endocrine Society, Midwest Society for Pediatric Research, Pediatric Endocrine Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

Thomas A Wilson, MD Professor of Clinical Pediatrics, Chief and Program Director, Division of Pediatric Endocrinology, Department of Pediatrics, The School of Medicine at Stony Brook University Medical Center

Thomas A Wilson, MD is a member of the following medical societies: Endocrine Society, Pediatric Endocrine Society, Phi Beta Kappa

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article